Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced B Cell Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04439136
What this trial is testing

Testing Afatinib as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol B)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 40
Early research (Phase 1)UnknownNCT05415098
What this trial is testing

Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas

Who this might be right for
Nasopharyngeal CarcinomaCastrate Resistant Prostate CancerGastric Cancer+6 more
Ascentage Pharma Group Inc. 90
Testing effectiveness (Phase 2)UnknownNCT05749549
What this trial is testing

Phase I/IIa Study of BR1733 in Subjects With Advanced Cancers

Who this might be right for
Advanced CancerFollicular LymphomaPeripheral T Cell Lymphoma+1 more
Shanghai Blueray Biopharma Co., Ltd. 191
Early research (Phase 1)Study completedNCT00642031
What this trial is testing

Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Patients With Advanced Hematologic Malignancies

Who this might be right for
Hematologic MalignanciesLeukemia
Prescient Therapeutics, Ltd. 20
Early research (Phase 1)Ended earlyNCT06254495
What this trial is testing

A Safety Study of PF-08046044/SGN-35C in Adults With Advanced Cancers

Who this might be right for
Hodgkin DiseaseLymphoma, T-Cell, PeripheralLymphoma, Large B-Cell, Diffuse+1 more
Seagen, a wholly owned subsidiary of Pfizer 58
Early research (Phase 1)Study completedNCT00944905
What this trial is testing

Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)

Who this might be right for
Renal Cell CarcinomaNon-hodgkin's Lymphoma
Bristol-Myers Squibb 46
Early research (Phase 1)Ended earlyNCT06028373
What this trial is testing

ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas

Who this might be right for
Advanced Solid TumorsB-cell Non-Hodgkin Lymphomas
Antengene Biologics Limited 38
Early research (Phase 1)Study completedNCT00275080
What this trial is testing

Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+48 more
National Cancer Institute (NCI) 80
Early research (Phase 1)Study completedNCT01482377
What this trial is testing

RO5479599 Alone or in Combination With Cetuximab or Erlotinib in Participants With Metastatic and/or Locally Advanced Malignant Human Epidermal Growth Factor Receptor (HER3) Expressing Solid Tumors of Epithelial Cell Origin

Who this might be right for
Neoplasms
Hoffmann-La Roche 145
Early research (Phase 1)Study completedNCT03424603
What this trial is testing

Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies

Who this might be right for
B-cell LymphomaNon Hodgkin LymphomaMultiple Myeloma+5 more
Sutro Biopharma, Inc. 70
Early research (Phase 1)Study completedNCT01098188
What this trial is testing

LFB-R603 Dose Finding in Patients With Advanced Stage B-Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Laboratoire français de Fractionnement et de Biotechnologies 33
Testing effectiveness (Phase 2)Ended earlyNCT01701037
What this trial is testing

Dabrafenib Alone and in Combination With Trametinib Before Surgery in Treating Patients With Locally or Regionally Advanced Melanoma That Can Be Removed By Surgery

Who this might be right for
Recurrent MelanomaStage IIB Melanoma (Locally Advanced)Stage IIC Melanoma (Locally Advanced)+4 more
Vanderbilt-Ingram Cancer Center 13
Early research (Phase 1)Study completedNCT00005807
What this trial is testing

Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer

Who this might be right for
Breast CancerOvarian CancerUnspecified Adult Solid Tumor, Protocol Specific
Albert Einstein College of Medicine 40
Early research (Phase 1)Study completedNCT00003289
What this trial is testing

UCN-01 in Treating Patients With Advanced Cancer

Who this might be right for
LeukemiaLymphomaUnspecified Adult Solid Tumor, Protocol Specific
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Not Yet RecruitingNCT07664735
What this trial is testing

Evaluate the Safety and Efficacy of OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.

Who this might be right for
Endometrial Cancer RecurrentEndometrial CancerAdvanced Endometrial Cancer+4 more
Outpace Bio, Inc. 30
Early research (Phase 1)Study completedNCT00004002
What this trial is testing

PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
NYU Langone Health
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Early research (Phase 1)Study completedNCT00562380
What this trial is testing

AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma

Who this might be right for
LymphomaProstate CancerSarcoma+2 more
Amgen 64
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00096096
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Fred Hutchinson Cancer Center
Next Page